CISD2 and hepatocellular carcinoma: Moreover, CISD2 suppressed sorafenib‐induced ferroptosis in drug‐resistant HCC cells by inhibiting Beclin1‐related cellular autophagy.[89] Lenvatinib has been approved for the treatment of advanced HCC; however, the underlying mechanism is not clear.